...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors
【24h】

Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors

机译:碳酸酐酶抑制剂选择性分析的化学信息化平台

获取原文
           

摘要

The selectivity for a specific human Carbonic Anhydrase (hCA) isoform is an important property a hCA inhibitor (CAI) should be endowed with, in order to constitute a valuable therapeutic tool for the treatment of a desired pathology. In this context, we developed a chemoinformatic platform that allows the analysis of the structure and selectivity profile of known CAIs reported in literature, with the aim of identifying structural motifs connected to ligand selectivity, thus providing useful guidelines for the design of novel ligands selective for the desired hCA isoform. The platform is able to perform ultrafast structure and selectivity analyses through ligand fingerprint similarity, with no need of structural information about the target receptor and ligands' binding mode. It is easily accessible to the non-expert user through the implementation of a KNIME Analytic Platform workflow and could be extended to analyze the selectivity profile of known ligands of different target proteins.
机译:特异性人碳酸酐酶(HCA)同种型的选择性是应赋予HCA抑制剂(CAI)的重要性质,以便构成用于治疗所需病理学的有价值的治疗工具。在这种情况下,我们开发了一种化疗的平台,可以分析文献中已知的CAIS的结构和选择性谱,目的是识别连接到配体选择性的结构基序,从而为设计的新型配体设计提供了有用的指导所需的HCA同种型。该平台能够通过配体指纹相似性执行超快结构和选择性分析,不需要有关目标受体和配体的结合模式的结构信息。非专家用户可以通过实现KNIME分析平台工作流程可以轻松访问,并且可以扩展以分析不同靶蛋白的已知配体的选择性曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号